The duration of treatment in the early stage of ankylosing spondylitis varies greatly depending on the patient’s physical condition, treatment plan and other factors, and cannot be generalized.
The early stage of ankylosing spondylitis generally refers to ankylosing spondylitis patients who do not yet have peripheral joint or spinal activity limitations, and this period of time the treatment is based on medication, and commonly used medications include non-steroidal anti-inflammatory drugs (NSAIDs) such as naproxen and celecoxib, as well as anti-rheumatic medications such as thalidomide, salazosulphadiazine, etanercept, infliximab and other anti-rheumatic medications.
The treatment plan for patients with ankylosing spondylitis needs to be individualized and customized according to the patient’s condition, and the time needed for treatment may vary greatly between patients with different conditions under different treatment plans.
Drugs need to be used under the guidance of a physician, it is recommended that patients with ankylosing spondylitis go to the rheumatology and immunology department of a regular hospital for detailed consultation and treatment as prescribed by the doctor.